Your support fuels our research to #EndALS!

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS Research News

Wednesday, December 29, 2021
Proudly Reflecting on ALS Research in 2020
A letter from the ALS Therapy Development Institute's (ALS TDI) Chief Scientific Officer, Fernando Vieira M.D.
read more
Friday, January 15, 2021
4 Things to Look for in ALS Research in 2021
Looking forward to the most exciting trends in ALS research in the new year.
read more
Tuesday, December 8, 2020
2020 ALS TDI Summit Highlights Progress and Collaboration in a Challenging Year
2020 was a year unlike any other, and so was this years's ALS TDI Summit.
read more
From trial readouts to news from our lab, you can find all of the latest ALS research news here.

ALS TDI Community Blog

Friday, December 31, 2021
We Will Continue to Work for You
A letter from the ALS Therapy Development Institute's (ALS TDI) Chief Executive Officer, Dr. Steve Perrin.
read more
Tuesday, January 19, 2021
We’re Moving to an Exciting new Location
I am excited to announce that this February, the ALS TDI lab will be moving to a brand new space in Watertown, MA.
read more
Tuesday, January 12, 2021
New Specialty License Plate Raise Funds, Aware for ALS TDI in Indiana
Drivers in the state of Indiana now have a new opportunity to support critical research to find effective treatments for Amyotrophic Lateral Sclerosis (ALS).
read more
Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Monday, November 2, 2020
Novus Therapeutics Announces Enrollment of First ALS Patient in Phase 2 Trials of AT-1501, A Drug Invented at ALS-TDI
The ALS Therapy Development Institute (ALS TDI) is excited to share a significant step in the advancement of AT-1501
read more
Monday, September 14, 2020
Acquisition of Anelixis Therapeutics Fuels Hopes of AT-1501 Push to Phase 2 Clinical Trials
The ALS Therapy Development Institute (ALS TDI) is excited to share that Anelixis Therapeutics, the
read more
Monday, April 27, 2020
Giving Tuesday Now with ALS TDI
#GivingTuesdayNow is scheduled to take place Tuesday, May 5, 2020.
read more
A complete list of press releases from the ALS Therapy Development Institute.
Follow Us
Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!
Media Contact
We'd love to share our story with you. Speak to our team about our unique approach to end ALS.